(Q39018781)

8 September 2017

title

Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma (English)

1 reference

8 September 2017

Shaojun Zhu

1

1 reference

8 September 2017

Yanhong Li

2

1 reference

8 September 2017

Yang Zhang

3

1 reference

8 September 2017

Xuxia Wang

4

1 reference

8 September 2017

Li Gong

5

1 reference

8 September 2017

Xiujuan Han

6

1 reference

8 September 2017

Li Yao

7

1 reference

8 September 2017

Miao Lan

8

1 reference

8 September 2017

Wei Zhang

9

1 reference

8 September 2017

publication date

10 April 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

45

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

97-106

1 reference

Primary liver cancer: worldwide incidence and trends

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Viral hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Links between CD147 function, glycosylation, and caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Metabolic activation-related CD147-CD98 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Tumorigenic potential of extracellular matrix metalloproteinase inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

High incidence of EMMPRIN expression in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Dealing with the family: CD147 interactions with cyclophilins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Inhibition of CD147 gene expression via RNA interference reduces tumor cell proliferation, activation, adhesion, and migration activity in the human Jurkat T-lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Risk factors for liver disease and associated knowledge and practices among Mexican adults in the US and Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Hepatitis viruses: live and let die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12320

21 January 2018

Identifiers

DOI

10.1111/HEPR.12320

1 reference

8 September 2017

1 reference